BIOGEN IDEC $231.33

up +6.15


21/5/2013 04:21 PM  |  NASDAQ : BIIB  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Last Trade: 231.33
Trade Time: May 21 4:04 PM Eastern Daylight Time
Change: 6.15 (2.73 %)
Prev Close: 225.18
Open: 226.17
Bid: 231.33
Ask: 232.61
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN

ETF Alternatives



People viewing BIIB also viewed: , , , ,

Competitors

Ticker Name Volume % Change
JGBO JIANGBO PHARMACEUTICALS 230.0 +2.25%
GNTAQ GENTA 2.9M +1.00%
ALSE ALSERES PHARMACEUTICALS 7.4K +0.67%
KDMP KEDEM PHARMACEUTICALS 437.4K +0.59%
ARNI ARNO THERAPEUTICS 7.5K +0.56%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
5/3/2013 Pawlicki Raymond SVP, Chief Information Officer -866 $218.85 -9.04%
5/3/2013 Cox John EVP Pharmaceutical Oper & Tech -866 $218.85 -4.58%
5/1/2013 COVINO GREGORY F VP, Chief Accounting Officer -114 $214.33 -23.31%
5/1/2013 SCANGOS GEORGE A Chief Executive Officer -1,598 $215.39 -3.07%
4/30/2013 Clancy Paul J Executive VP and CFO -900 $226.01 -11.27%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (BIIB), click here.
View All

BIIB Stock Analysis

  1. Amgen Chased By The Bubble

    (AMGN,PFE,SNY,TEVA,CELG,NVO,MRK,HSP,ABT,AFFY,BIIB,GILD )
    Amgen really needs the pipeline to come through to support this valuation.
Free Reports
  1.

    Find the Best Mortgage Rates

    Search and compare the best fixed and adjustable mortgage rates in your area with Bankrate.com.
  2.

    Free Managed Futures Book

    Get the four benefits of managed futures as outlined in this booklet.
  3.

    3 Stocks Peter Lynch Would Buy Today

    This new special report identifies 3 stocks based on Lynch’s market-trouncing strategy that could more than double in the next 12 months.
Marketplace
Trading Center